Wednesday, July 8, 2026

pharma · Contraception · Chlamydia Trachomatis Infection · EVFM

Evofem Biosciences

Evofem Biosciences is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker EVFM. Primary therapeutic focus areas include Contraception, Chlamydia Trachomatis Infection, Sexually Transmitt

San Diego, USA HQ
2015 Founded
39 Employees
Public company Type
EVFM · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2015
Employees
39
Programs
6
Drugs
2
Patents
8
Clinical program

Acidform 5 g

Phase 1 · small molecule · Healthy

Acidform 5 g for Healthy is a Phase 1 program (small_molecule) at Evofem Biosciences with 1 ClinicalTrials.gov record(s).

← All Evofem Biosciences projects Phase 1 small molecule completed

Internal code EVO-002

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Evofem Biosciences
Phase
Phase 1
Modality
small_molecule
Indication
Healthy
Status
completed
Trials
1

Clinical trials